Get the Stockscreener App
3.79
5.25%
-0.21
Aclarion Inc stock is traded at $3.79, with a volume of 323.32K.
It is down -5.25% in the last 24 hours and down -37.25% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$4.00
Open:
$4
24h Volume:
323.32K
Relative Volume:
0.42
Market Cap:
$4.00M
Revenue:
$49,300
Net Income/Loss:
$-6.27M
P/E Ratio:
-0.4169
EPS:
-9.09
Net Cash Flow:
$-5.38M
1W Performance:
-20.71%
1M Performance:
-37.25%
6M Performance:
-48.78%
1Y Performance:
+211.93%
1-Day Range:
$3.68
$4.00
1-Week Range:
$3.68
$4.87
52-Week Range:
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
3.79 | 4.22M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
222.21 | 35.99B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.33 | 12.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
41.26 | 7.73B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
85.37 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.20 | 7.14B | 11.99B | 24.18M | 234.31M | 0.2956 |
Aclarion Inc Stock (ACON) Latest News
Pharma News: Is Perpetua Resources Corp forming a bullish divergenceWeekly Trading Summary & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Decliners Report: Will Aclarion Inc stock recover after earnings2025 Major Catalysts & Proven Capital Preservation Methods - baoquankhu1.vn
Is the Market Bullish or Bearish on Aclarion Inc? - Sahm
Aclarion raises $10.4 million to fund chronic back pain technology By Investing.com - Investing.com Nigeria
Risk Check: Will Aclarion Inc stock gain from government policiesProfit Target & Daily Profit Focused Stock Screening - Bộ Nội Vụ
Aug Update: What are Aclarion Incs earnings expectations2025 Performance Recap & Daily Profit Maximizing Tips - baoquankhu1.vn
Med-tech startup Aclarion raises $10.4M in stock sale - BizWest
Healthcare Stocks To Keep An Eye OnJanuary 8th - MarketBeat
What's Going On With Aclarion Stock Tuesday?Aclarion (NASDAQ:ACON) - Benzinga
Profit Recap: Why Aclarion Inc. stock appeals to dividend seekers2025 Technical Patterns & Accurate Buy Signal Alerts - Bộ Nội Vụ
Aclarion Incextends cash runway into 2028SEC filing - marketscreener.com
Aclarion Strengthens Balance Sheet With New Equity Financing - TipRanks
Aclarion, Inc. Closes $10.4 Million Financing to Extend Cash Runway - TradingView — Track All Markets
Aclarion raises $10.4 million to fund chronic back pain technology - Investing.com
Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028 - The Manila Times
Aclarion, Inc. Secures $10.4 Million in Common-Stock Financing to Strengthen Balance Sheet and Extend Operating Runway - Quiver Quantitative
Debt-free Aclarion now holds $21.6M to grow its AI back pain tool - Stock Titan
Published on: 2026-01-13 07:30:48 - Улправда
Aclarion to enroll around 25% of patients in CLARITY trial by Q2 - MSN
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data - ADVFN
Healthcare Stocks To Keep An Eye On – January 8th - Defense World
How Aclarion Inc. stock reacts to global recession fearsJuly 2025 Intraday Action & Accurate Intraday Trade Tips - Улправда
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Dow Edges Higher; US Economy Adds 50,000 Jobs In December - Benzinga
Aclarion Announces $10.4 Million Registered Direct Offering - TipRanks
Aclarion Signs Multiple Material Agreements - TradingView — Track All Markets
Why Tilray Brands Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Aclarion, Inc., (ACON) stock: surges 39% as Nociscan adoption accelerates into 2026 - parameter.io
ACON Stock Pops 45% Pre-Market Today: What’s Driving The Move? - Stocktwits
Aclarion Stock Climbs 50% After Strong 2025 Results And 2026 Outlook - Nasdaq
Aclarion Inc.: Analyzing the Sudden Surge - StocksToTrade
Is Aclarion Inc. Equity Warrant stock a safe haven assetPortfolio Risk Summary & Fast Moving Market Watchlists - ulpravda.ru
Will Aclarion Inc. stock reach all time highs in 2025Insider Buying & Entry Point Confirmation Signals - Улправда
Is Aclarion Inc. Equity Warrant stock overvalued by current metricsJuly 2025 Breakouts & Safe Entry Trade Signal Reports - Улправда
Aclarion Provides 2025 Update and 2026 Corporate Outlook - The Globe and Mail
Why Aclarion Inc. stock appeals to dividend seekers2025 Institutional Moves & Consistent Growth Equity Picks - Улправда
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Aclarion’s Stock Rocket: Is It Too Late? - timothysykes.com
Aclarion stock soars on 114% jump in Q4 Nociscan scan volumes - Investing.com Nigeria
Aclarion stock soars on 114% jump in Q4 Nociscan scan volumes By Investing.com - Investing.com South Africa
Why Is Aclarion Stock Skyrocketing Thursday?Aclarion (NASDAQ:ACON) - Benzinga
ACON Stock Price and Chart — NASDAQ:ACON - TradingView — Track All Markets
Why Is Aclarion Stock (ACON) Up Today? - TipRanks
Morning Market Movers: ACON, ASPC, IMRX, NVVE See Big Swings - RTTNews
ACON Stock Price Today - Stock Titan
ACON stock pops 45% pre-market today: What’s driving the move? - MSN
Aclarion's 2025 Nociscan Scan Volumes Hit Record High, Shares Surge 45% - Nasdaq
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Aclarion Inc. stock is seen as undervalued2026 world cup usa national team third place match key players possession football knockout prediction tactical review - ulpravda.ru
Aclarion says first patients enrolled at two additional CLARITY trial sites - TipRanks
Aclarion announces first patient enrollments at two additional Clarity trial sites - marketscreener.com
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.21%
2.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):